IntroductionCaused by Shigella species, shigellosis is an infectious disease which is endemic in many developing countries. 1 Annually, there are about 80 million cases of bloody diarrhea and 700 000 deaths due to this infection. 2 Children under 5 years old, elderly, and immunocompromised people are at a higher risk to this infection and develop more severe symptoms. 3,4 The majority of the disease cases are seen in developing countries and it is due to the poor hygiene standards, poor water quality, etc. 5 Four different species of Shigella genus can develop the disease, Shigella sonnei, Shigella dysenteriae, Shigella flexneri, and Shigella boydii. The incidence of the species is so different in various countries: while S. flexneri is the prevalence serogroup in developing countries, the most cases of the infection in developed countries are caused by S. sonnei. 6,7 Since it is transmitted via fecal-oral rout in a low dose (1-500 organisms) and also via direct spread by person to person contact, the control of the infection is a great challenge. 8,9 Shigella infection can cause different symptoms from a mild self-limiting diarrhea to severe dysentery associated with blood and mucus excretion, high fever, and cramps. 10,11 Since there is no approved vaccine, despite all attempts, 12-14 antibiotic therapy is the main strategy to combat the disease. Appropriate antibiotic therapy shortens the disease symptoms and prevents the life-threatening effects, also, it decreases the bacterial shedding in feces and, therefore, decreases the bacterial spread. 15 However, during recent decades, the indiscriminate use of antibiotics has led to the resistance of Shigella spp. to common antibiotics. 16,17 Due to the self-limiting nature of the